The Johnson & Johnson COVID-19 vaccine is less effective against the Indian 'Delta' coronavirus variant than other shots, a new study suggests. Antibody levels among people who received Johnson & Johnson's COVID-19 vaccine were low against the Indian 'Delta' coronavirus variant. There is no specific data released yet on the efficacy of the Moderna vaccine against the Delta variant. However, a Canadian study found the first dose of the Moderna vaccine was 72 percent effective against infection from the Delta variant. 'I have always thought, and often said, that the J&J vaccine is a two-dose vaccine,' he said.

Source: Daily Mail July 20, 2021 21:01 UTC